Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (72 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Rare Encouragement Offered
View:
Post by made2last on Jun 14, 2024 5:14pm

Rare Encouragement Offered

Hi all;

News release reminder of AGM. This is unusual communication from TLT management. I find this very encouraging. Perhaps good news is near!

Good luck all;

made2last
Comment by Oilminerdeluxe on Jun 15, 2024 3:03am
They have plenty of things to talk about at the AGM  if they want to. The recent releases have been very promising. How far developed  are the plans to push those things further? That tiny issue of money. If they somehow were to get hold of the needed capital, I think the relief rally will be eternal, lol. Fingers crossed they have the funds real soon. What other way can they go if they ...more  
Comment by plantrader on Jun 15, 2024 8:37am
I don't really understand it. A NR just to "remind" everyone about the AGM? They can't talk about anything new/material at the AGM unless it's already been announced previously, right? This kind of trivial NR seems out of character for them. 
Comment by Rumpl3StiltSkin on Jun 15, 2024 8:52am
Maybe there is another NR between now and then? :-)
Comment by StevenBirch on Jun 15, 2024 9:22am
We have had some positive news releases lately and now they are trying to raise more money in less time than previous PPs, it's hard not to be optimistic.
Comment by Johnandrose22 on Jun 15, 2024 9:25am
Perhaps, it is precisely because this NR is so "out of character" that it could bear significance. It's as though the company is saying to investors "Don't miss this one". We shall know soon. I, too, believe there will be another NR before the AGM. John
Comment by livermore2 on Jun 15, 2024 12:39pm
The meeting is taking place after trading hours so think they can talk pretty freely and news release for next trading day. When companies emphasize the "special" part of AGM it usually leads to something material. Let's hope for exciting news for all the longs -our day could be near!
Comment by menoalittle on Jun 15, 2024 12:54pm
Interesting.  That doesn't seem very likely or intentional... but I haven't really thought much about it.  Perhaps if something material is said or talked about (even if by mistake), I suppose the company could always request a trading halt before the next morning (with news pending) until they have had time to put an appropriate news release together. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250